Associate VP, New Business Development & Alliance Management – Oncology

Your role This is a unique opportunity to join Orion Pharma’s Innovative Medicines business division as it expands its global footprint from Europe to the Americas and Asia. We are seeking a high-caliber Business Development leader to lead strategic sourcing, evaluation, and execution of external innovation opportunities in oncology, with a primary focus on in-licensing, partnerships, and acquisition transactions. This role is responsible for identifying high-value assets and technologies aligned with the company’s therapeutic priorities, driving end-to-end deal execution, and shaping long-term portfolio strategy through external innovation. Responsibilities • Lead identification, evaluation, and prioritization of in-licensing and acquisition opportunities across priority therapeutic areas, with a strong emphasis on scientific and commercial fit • Drive end-to-end transaction execution, including deal structuring, valuation, negotiation, and internal governance approvals • Partner closely with R&D, clinical, regulatory, commercial, and finance teams to assess opportunities, define target product profiles, and build robust business cases • Maintain deep external network across biotech, venture capital, academia, and industry to proactively source differentiated opportunities • Lead cross-functional due diligence teams, synthesizing scientific, clinical, regulatory, and commercial insights into clear investment recommendations • Develop and execute partnering strategies aligned with corporate and therapeutic area strategies • Monitor competitive landscape, emerging science, and deal trends to inform proactive business development efforts This role reports to Vice President, Business Development & Partnerships, Innovative Medicines. This position is based in Cambridge, MA, US. What you can expect from us At Orion, your work creates true impact and well-being for our customers, patients and society at large. ​ ​Our culture of friendliness, respect, mutual appreciation and diversity creates a safe working environment where you can strive for excellence. We offer a wealth development opportunities that support the development of innovative solutions and improving the quality of life. Please visit our website to find further information about our values and Orion as an employer https://www.orion.fi/en/careers/orion-as-an-employer/ . What are we looking for? • Advanced degree (PhD, MD, PharmD, or MBA) with strong scientific foundation; additional business training preferred • 10 to 15+ years of experience, with significant experience in business development, licensing, or M&A prior experience in multi-national biopharma is preferred • Demonstrated track record of leading and closing complex transactions, including licensing and acquisitions • Excellent negotiation, communication, and stakeholder management skills, with the ability to influence senior leadership • Comfortable reviewing legal contracts alongside attorneys • Strong financial and accounting acumen, including building valuation models (e.g., rNPV) and developing realistic scenarios • Deep understanding of oncology drug development, clinical trial design, regulatory pathways, and commercialization dynamics • Exposure to early-stage and late-stage dealmaking across modalities (small molecules, biologics, etc.) • Ability to operate effectively in a highly matrixed, global organization • Experience in alliance management across multiple active partnerships How to apply If this role aligns with your interests and aspirations, we encourage you to apply no later than September 9th, 2026. We typically review applications already during the application period and may start interviewing candidates before the application deadline. Therefore, we invite you to send your application as soon as possible. #LI-ORION Your new team The Innovative Medicines business division is responsible for the strategic leadership of Orion’s business in core therapy areas, Pain and Oncology, covering all activities from pipeline and portfolio building to the commercialization of new, innovative medicines in Pain and Oncology. Innovative Medicines aims to provide an agile platform for Orion to compete in the pharmaceutical sector. In Innovative Medicines Business Division, the unmet need of the patient meets innovation that brings the best, new treatments to promote health and well-being in society. Orion’s pharmaceutical innovations are created within its R&D organization. We employ top professionals in the field of drug discovery and development. We work globally: in Espoo and Turku in Finland, in Cambridge and Nottingham in England and in Cambridge, USA. Orion R&D and the Innovative Medicines business division are dedicated to becoming a global player in oncology and pain therapy areas.